b-12
AI Nativeb12 is an AI copilot for chemical lab experiments for pharma and biotech.
Est 2025|Raised $500K
Published Aug 14, 2026
No credible market share estimates for b-12 were identified. This is consistent with an early-stage company founded recently.
| Starting Price | Not public (demo/quote) | Not transparently listed; enterprise-oriented | Hardware pricing varies; used market shows lower-cost options for basic platforms |
| Appropriate For | Teams seeking a natural-language-driven interface that maps experimental intent to automation execution | R&D teams needing an ELN/LIMS and workflow/documentation platform | Labs seeking affordable automation hardware and willing to develop protocols in-house |
| Key Strength | Vendor describes a workflow from natural-language intent to protocol generation and execution | Mature platform adoption; broad R&D workflow coverage | Relatively transparent hardware pricing for baseline automation; strong protocol community |
| Key Weakness | Limited public proof points (limited public reviews or case studies); integration and pricing details are not published | Can require enterprise procurement processes and may be perceived as costly | Less focused on AI-driven protocol generation; requires automation expertise |
—